Abstract:
Disclosed is an occluder for closing an intracardiac defect, such as a patent foramen ovale (PFO), and a method for making the same. The occluder includes a frame and at least one scaffold which are formed from a bioabsorbable polymer, such as poly-4-hydroxybutyrate. The surface of the frame and scaffold are textured to promote cell attachment. Texturing of the surface can be achieved by any number of mechanical or chemical procedures. The device is coated with collagen and heparin which are covalently bound to the surface of the device. The occluder provides improved defect closure compared to other septal occluders known in the art. In particular, the occluder described is specifically designed to improve host cell attachment to and tissue ingrowth over the device when implanted in a patient as compared to the level of host cell attachment and tissue ingrowth achieved with other implantable devices made of bioabsorbable polymers.
Abstract:
This application relates to a syringe-activated valve (100) for flushing a catheter for delivering an implant to an anatomical site, such as a patent foramen ovale in a patient and method thereof . In one embodiment, a catheter includes a proximal end, a distal end, a "Y" connector (320) at the proximal end, the "Y" connector having a guide wire port (301) and a connector port (310), a syringe activated valve having a first end and a second end, the second end of syringe-activated valve connecting to the connector port of the "Y" connector, and a syringe (200) connecting to the first end of the syringe-activated valve. Saline is injected by the syringe through the syringe-activated valve into the proximal end of the catheter, thereby flushing air from the catheter lumen out of the distal end of the catheter.
Abstract:
The invention generally relates to devices and methods for treating cardiac tissue, including percutaneous closure of cardiac openings such as a patent foramen ovale (PFO) and obliteration of the cardiac cul-de-sacs. The invention includes a device having at least one elongated member. The elongated member has a first material and a second material interwoven with at least a portion of the first material. The second material is capable of transferring energy to tissue in need of treatment.
Abstract:
The invention generally relates to devices and methods for treating cardiac tissue, including percutaneous closure of cardiac openings such as a patent foramen ovale (PFO) and obliteration of the cardiac cul-de-sacs. The invention includes a device having at least one elongated member. The elongated member has a first material and a second material interwoven with at least a portion of the first material. The second material is capable of transferring energy to tissue in need of treatment.
Abstract:
A go no-go gauge and method for verifying whether a process kit part used within a plasma chamber of a plasma processing tool has accumulated excessive wear or deposits. The gauge includes a component for verifying whether a dimension of a process kit part feature violates a prescribed size tolerance, the violation indicating that the process kit part has accumulated excessive wear or deposits.
Abstract:
The invention generally relates to devices, systems, and methods for percutaneous closure of cardiac openings and obliteration of the cardiac cul-de-sacs. In one embodiment, a closure device includes a patch with an adhesive and/or a removable frame. The patch may be placed across a cardiac opening, such as a patent foramen ovale, or across a cardiac cul-de-sac, such as a left atrial appendage. In another embodiment, a closure device includes a balloon together with adhesive and/or substances for stimulating tissue growth coated on, or contained within, the balloon. The balloon may be inserted into a cardiac opening, such as the patent foramen ovale, or into a cardiac cul-de-sac, such as a left atrial appendage.
Abstract:
An expandable catheter accommodates a medical device that is being removed from a body with a larger diameter than the catheter. The same catheter may be used to reposition a device within the body to an alternative delivery site. A catheter or sheath may be used to deliver a medical device, surgical instrument, or biological sample.
Abstract:
Apparatus, systems, and methods for forming a hole in biological material, such as tissue walls, adjacent vessels or adjacent regions of an organ such that access to opposing surfaces of the biological material can be achieved. In general overview the system may include ,an elongate member for positioning and deploying a flexible member in the heart. In one embodiment apparatus and methods are provided for aligning and fixing the position of the tip of a cutting member for cutting a hole in the septal wall of a heart. In another embodiment, subsequent to cutting a tissue wall an apparatus for obstructing holes in the septal wall is inserted to limit the flow of blood through a plurality of holes in a tissue wall.
Abstract:
A hemostasis valve includes a single gland (16) with multiple offset longitudinal slits (32/34) that do no extend through the gland (16) completely. The multiple slits (32/34) from a complex pathway for the guide dilator/catheter (58) and thus a better seal. The offset slits (32/34) are joined by a lateral cut (36) in the gland. When a guide wire or dilator/catheter (58) is introduced into the introducer, the gland (16) deforms sufficiently to allow the guide wire or other device (58) to move through the first slits (32), the lateral cut (36) and the second slits (34). This complex pathway or slit provides a larger sealing surface thereby creating a better seal. As a result, effective seals may be formed around relatively large, as compared to the inner diameter of an introducer sheath, catheters.
Abstract:
A medical device made from a shape memory alloy has portions with a first recovery force, and other portions with a second recovery force in desired locations, such as ends that contact portions of the body, such that the second recovery force is less than the first recovery force.